Secondary prevention for ischemic heart disease: Relative numbers needed to treat with different therapies

Archives of Internal Medicine

Volumn 157, Issue 18, 1997, Pages 2045-2052

  Miller, David B ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Greater Victoria Hospital Society   (Canada)

^c Int Med Endocrinol and Metab   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHENPROCOUMON; PRAVASTATIN; PROPRANOLOL DERIVATIVE; RAMIPRIL; SIMVASTATIN; SOTALOL; TIMOLOL MALEATE; WARFARIN;

ADULT; CALCULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANOMALY; CORONARY ARTERY DILATATION; DIET THERAPY; ENZYME INHIBITION; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; TREATMENT PLANNING;

EID: 0030964668     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.18.2045     Document Type: Review

References (9)

1. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston, Mass: Little Brown & Co; 1991.
2. Aspirin Myocardial Infarction Study Research Group. The Aspirin Myocardial Infarction Study: final results. Circulation. 1980;62(suppl V):V-79-V-84.
3. Coronary Drug Project Research Group. Aspirin in coronary heart disease. Circulation. 1980;62 (suppl V):V-59-V-62.
4. Breddin K, Loew D, Lechner K, Oberla K, Walter E. The German-Austrian Aspirin Trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. Circulation. 1980;62(suppl V):V-63-V-72.
5. Persantine-Aspirin Reinfarction Study (PARIS) Research Group. The Persantin-Aspirin Reinfarction Study. Circulation. 1980;62(suppl V):V-85-V-89.
6. Klimt CR, Knatterud GL, Stamler J, Meier P. Persantine-Aspirin Reinfarction Study, II: secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol. 1986;7:251-269.
7. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet. 1992;340:1421-1425.
8. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990;323:147-152.
9. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet. 1994;343:499-503.